Home / Diabetes In Control (page 306)

Diabetes In Control

Statin Side-effects Questioned

  Only a small minority of symptoms reported on statins are genuinely due to the statins, and only 1 in 5 new cases of development of new-onset diabetes mellitus while on statins could actually be attributed to the medications….

Read More »

Do Saturated Fats Really Cause Heart Disease?

An international research collaboration led by the University of Cambridge analysed existing cohort studies and randomised trials on coronary risk and fatty acid intake. They showed that current evidence does not support guidelines which restrict the consumption of saturated fats in order to prevent heart disease….

Read More »

Special GLP-1 Edition, March 2014

There is no doubt that all too many times in the past we have heard great news on non-injectable insulin drugs. First we had inhaled, which flopped and buccal which seems to be stuck in other countries except the U.S. Over the past 10 years we have had over 30 …

Read More »

Alternative GLP-1 Delivery Systems

Although glucagon-like peptide-1 (GLP-1) is highly biologically active following intravenous or subcutaneous injection, a non-injectable alternative for activating GLP-1 receptor signaling would clearly be desirable. Studies by Gutniak, Ahren and colleagues in Sweden have shown that GLP-1 formulated in buccal tablets is absorbed into the circulation and lowers blood glucose …

Read More »

Letter from the Editor #721:

This past Friday I had the pleasure of presenting a CE program at the annual meeting of the Washington Association of Diabetes Educators. There were 250+ diabetes educators in attendance and we were talking about the use of new technology. During the program I asked those in the room about …

Read More »